Emotional Challenges in Gynecologic and Breast Cancer: From Diagnosis Through Survivorship

Written By Jess Coleman, Ph.D.

Table of Contents

A cancer diagnosis changes everything, and not only in the ways that are most visible. The physical demands of treatment, the decisions that must be made quickly, the appointments and procedures, waiting for results — these are the parts of cancer care that the medical system is organized around. The emotional experience of living inside all of it is something else, and it is something the medical system is far less equipped to address.

Breast cancer and gynecologic cancers, which include endometrial, cervical, ovarian, vulvar, and vaginal cancers, involve the most intimate parts of a person's body. They can affect fertility, sexual health, hormonal function, body image, and the felt sense of self in ways that are profound and often underacknowledged. The psychological impact of these diagnoses does not stay neatly within the boundaries of treatment. It extends across diagnosis, through the demands of active treatment, into survivorship, and often long beyond the point where the medical world considers the journey over.

This post is for people navigating breast or gynecologic cancer at any stage — and for anyone who wants to understand what that journey involves emotionally. It draws on the research literature and on my own clinical and research work at Duke University, where I studied the psychological impact of gynecologic cancer survivorship and developed a cognitive behavioral intervention for gynecologic cancer survivors experiencing anxiety and distress during surveillance pelvic exams.

The emotional weight of diagnosis

Receiving a cancer diagnosis is a profound disruption. Whatever your life looked like before the appointment where everything changed, it looked different afterward. The diagnosis arrives, often suddenly, often in a clinical setting that does not have the space or time to hold the full weight of what has just been said, and everything reorganizes around it. Research consistently documents high rates of psychological distress — including shock, disbelief, fear, and grief — that follow breast and gynecologic cancer diagnoses. These emotions are appropriate responses to news that carries real weight about mortality, the body, and the future.

What makes the emotional experience of breast and gynecologic cancer diagnosis particularly complex is the intimacy of what is being affected. These are not cancers that feel distant from the self. They involve the breasts, the uterus, the ovaries, the cervix: organs that carry meaning related to femininity, sexuality, fertility, and identity in ways that differ from person to person but are rarely neutral. A diagnosis in these parts of the body can activate fears and feelings that go well beyond the medical facts of the situation, and it deserves to be treated with care.

The period immediately following diagnosis is also one of extraordinary practical demand. Appointments must be made, treatment decisions must be considered, second opinions may need to be sought, insurance and work and family and logistics must all be managed, often before there has been any space to absorb what is happening emotionally. This collision of acute emotional distress and urgent practical demand is one of the most difficult features of the diagnosis period, and it is one that very few people are warned about.

Decision fatigue and scanxiety: the anxiety that lives in uncertainty

Cancer care involves an enormous number of decisions, many of which must be made quickly and with incomplete information. Which treatment path to pursue. Whether to pursue genetic testing. Whether to seek a second opinion and how to navigate that without alienating a care team. Whether to pursue fertility preservation before treatment begins. These decisions carry weight and often must be made in a state of emotional shock, under time pressure, and without the benefit of being able to know in advance what the outcomes will be.

Decision fatigue — the cognitive and emotional depletion that comes from making repeated high-stakes choices — is a significant but rarely named feature of the cancer experience. Throughout active treatment and into survivorship, decisions continue: about medication, about follow-up care, about when and how to return to work, about how to talk about what is happening with children and family and colleagues.

Layered onto decision fatigue is what researchers and many survivors call scanxiety — the anxiety that builds in the period before imaging, bloodwork, or surveillance appointments. Research on breast and gynecologic cancer survivors finds that fear of cancer recurrence and scan-related anxiety share common mechanisms, including intolerance of uncertainty and heightened bodily threat monitoring. Scanxiety is not irrational. It reflects the experience of having had a serious illness, of knowing that surveillance tests exist because recurrence is possible. Managing it requires more than reassurance — it requires building practical coping tools.

Medical anxiety and invasive procedures during and after treatment

Breast and gynecologic cancer treatments involve a significant number of invasive procedures — such as biopsies, surgeries, radiation, brachytherapy, chemotherapy infusions, imaging, and, for gynecologic cancer survivors, a structured schedule of surveillance pelvic exams in the years following treatment. Each of these carries its own psychological weight, and for many patients, the cumulative experience of repeated invasive procedures becomes a significant source of anxiety and distress in its own right.

Pelvic radiation, surgery, and hormone depletion often cause vaginal changes including scarring and vaginal shortening that require genitally invasive follow-up care such as vaginal dilators, pelvic floor physical therapy, and frequent pelvic exams. Many patients report these procedures as distressing and painful, which can negatively impact their engagement in care.

This is an area I studied directly during my doctoral work at Duke. My research focused on the psychological experience of gynecologic cancer survivors undergoing surveillance pelvic exams — a procedure that is critical for early detection of endometrial and cervical cancer recurrence, and one that patients frequently report causes high levels of anxiety, pain, and discomfort. Through qualitative interviews with patients and providers, my colleagues and I developed the PEACE intervention, a cognitive behavioral coping skills program designed to help survivors manage anxiety and distress before and during these exams. PEACE responds to a significant need for evidence-based, trauma-informed interventions in OB/GYN settings.

What this research made clear is that the distress associated with these procedures is real, it is common, and it does not have to simply be endured. Evidence-based coping skills — including muscle tension release, mindfulness, and assertive communication with providers — can meaningfully reduce anxiety and increase a sense of agency during procedures that can otherwise feel entirely outside a person's control.

For anyone navigating anxiety about medical procedures related to cancer diagnosis, treatment, or surveillance: this is not something you simply have to white-knuckle through. Support is available, and it works.

When sexual violence history intersects with gynecologic cancer care

Gynecologic cancer care involves parts of the body that also carry the history of gender-based violence for a significant proportion of patients. More than 1 in 3 women have experienced some form of unwanted sexual violence, including rape, sexual coercion, and unwanted sexual contact. For people with that history, gynecologic procedures such as pelvic exams, speculum insertions, biopsies, brachytherapy, and dilator use can activate anxiety or trauma responses that are not always anticipated and are not always noticed or addressed by providers.

In my published research at Duke, my colleagues and I conducted a systematic review of the psychological distress and pain associated with gynecologic exams among female survivors of sexual and physical violence. Our findings indicated that survivors of violence experience mild-to-severe levels of distress and mild-to-moderate levels of pain during gynecologic exams.

This intersection between a history of sexual violence and the invasive demands of gynecologic cancer care is one of the least discussed and most clinically significant aspects of this population's experience. It is not a niche concern. Given how many people have experienced sexual violence, and how central pelvic procedures are to gynecologic cancer care, these two realities overlap for an enormous number of patients.

Addressing this intersection requires more than sensitivity on the part of individual providers, though that matters greatly. It requires systematic, trauma-informed approaches to care — and it requires that patients themselves have access to psychological support that understands both the cancer experience and experiences of sexual violence, and can help them navigate the clinical demands of their care without being retraumatized in the process.

Sexual health impacts during and after treatment

Sexual health is among the most consistently affected and least consistently addressed dimensions of the breast and gynecologic cancer experience. The prevalence of bothersome sexual dysfunction among gynecologic cancer survivors is much greater than in the general female population. For breast cancer survivors, the picture is similarly significant, driven by the effects of surgery, chemotherapy, radiation, hormonal therapies, and medically induced menopause on desire, arousal, lubrication, pain, and overall sexual satisfaction.

Despite this prevalence, sexual health is frequently not addressed in oncology care. Patients often do not raise the topic because they feel it is not appropriate to bring up, because they do not want to seem ungrateful for surviving, or because they have received implicit messages from their care team that sexual functioning is not a priority relative to survival. Providers often do not raise it because of time constraints, discomfort with the topic, or a lack of training in how to address it. Without intervention — and unlike other side effects of treatment — sexual problems tend to persist or worsen over time.

The specific impacts depend on the type of cancer and treatment. Gynecologic cancer treatment frequently affects vaginal tissue directly through radiation, surgery, and hormone depletion, causing changes in elasticity, lubrication, sensation, and comfort. Breast cancer treatment, particularly hormonal therapies such as aromatase inhibitors and chemotherapy-induced menopause, can produce significant genitourinary changes alongside alterations in desire and arousal. For many survivors, these changes affect not only physical sexual function but also body image, intimacy, and the felt sense of connection with a partner.

Sexual health concerns after cancer are legitimate medical and psychological concerns. They deserve to be named, screened for, and addressed with high-quality care.

Grief — for fertility, for the body, for the self

Grief is often a consistent companion across the breast and gynecologic cancer journey, and it takes forms that are not always recognized as grief because they do not involve the death of a person.

There is grief for the body that existed before diagnosis. The changes wrought by surgery, radiation, chemotherapy, and hormonal treatment are real and often permanent. A mastectomy, a hysterectomy, hair loss, weight changes, scars, lymphedema: these are alterations to the physical self that carry meaning, and that deserve to be mourned rather than simply managed. Many people feel pressure to be grateful for survival in a way that forecloses grieving the losses that came with it. Gratitude and grief can coexist. Survival does not cancel the legitimacy of loss.

There is grief for the self that existed before diagnosis: the person who moved through the world without this knowledge, who made plans without accounting for this future reality, who had a different relationship with the body and with the future. The identity disruption of a cancer diagnosis is real and lasting, and it is rarely given adequate space in the medical system.

And there is, for many people, grief related to fertility: either the loss of fertility as a result of treatment, or the foreclosure of reproductive possibilities that were part of an imagined future. For younger women in particular, gynecologic cancer treatment can involve decisions about fertility preservation that must be made with extraordinary speed, often before there has been time to absorb the diagnosis itself. The grief that follows these decisions — whether a person chose to preserve fertility or did not, whether the preservation succeeded or failed — can be profound and prolonged.

Fertility preservation and medically induced menopause

Fertility is a central concern for many people diagnosed with breast or gynecologic cancer at reproductive age. Chemotherapy, radiation to the pelvis, and surgical removal of the ovaries or uterus can all affect fertility, temporarily or permanently, and the decisions surrounding fertility preservation are among the most emotionally charged that cancer patients face.

These decisions must often be made rapidly, before treatment begins, under conditions of acute shock and grief. The options — including embryo freezing, egg freezing, and ovarian tissue cryopreservation — require time, resources, and a window that may not always be available. For people who did not have the opportunity or the resources to pursue preservation, or whose preserved embryos or eggs did not result in a pregnancy, the grief can be significant.

Medically induced menopause — whether through surgical removal of the ovaries, radiation damage to ovarian function, or hormonal suppression therapy — is another major dimension of the fertility and hormonal impact of cancer treatment. For women who experience menopause abruptly and at a younger age than expected, the physical symptoms such as hot flashes, vaginal dryness, sleep disruption, cognitive changes, and mood changes are often more severe than those of natural menopause. The psychological impact of this abrupt hormonal shift is frequently underestimated and underaddressed. There is also often grief related to experiencing medically induced menopause. For people who experienced menopause as the end of a reproductive chapter they had not finished, or as a permanent change to the body at an age when they had not anticipated it, this transition carries emotional weight that deserves acknowledgment beyond symptom management.

Survivorship and the emotional transition out of active treatment

The end of active cancer treatment is often framed as a milestone. For many survivors, it does not feel that way. It can feel disorienting, isolating, and frightening in ways that catch people entirely off guard.

During active treatment, there is structure: appointments, a care team, a clear sense of what is being done and who is monitoring. When treatment ends, the structure disappears. Appointments become less frequent. The care team recedes. The surveillance schedule begins, which involves watching and waiting rather than actively treating. For many survivors, this transition produces a new wave of anxiety rather than relief, because the thing that felt protective — the active intervention and frequent appointments — is no longer happening.

There is also the experience of stepping back into a world that has continued moving. People may feel pressure to return to their previous roles and functioning at a pace that does not reflect where they actually are. The expectation from employers, from family members, from the broader social world that survivorship means recovery can leave people feeling that they are somehow failing by still struggling.

Survivorship is not a return to the life that existed before. It is the beginning of a different life, one that carries new knowledge, new physical realities, and new psychological demands alongside whatever continuity with the past is possible. The emotional work of survivorship deserves as much attention and support as the work of active treatment, and it often receives far less.

Fear of cancer recurrence

Fear of cancer recurrence — the persistent, often intrusive concern that cancer will return — is one of the most universally reported and most underaddressed dimensions of cancer survivorship. It is not always a phase that passes once enough time has elapsed. For many survivors, it is a chronic feature of life after cancer, with intensity that fluctuates but does not simply disappear.

Fear of recurrence is common and often long-lasting, manifesting as constant and intrusive thoughts about cancer regardless of actual prognosis or risk, and can cause increased use of health services and non-adherence to treatment and follow-up. For gynecologic cancer survivors, research identifies the negative effects of cancer on sexuality and relationships, anxiety about future treatments, emotional difficulties, and worry about not being able to fulfill roles at home and work as underlying contributors to fear of recurrence.

Fear of recurrence is not irrational — it is the brain's response to having had a genuinely threatening experience, remaining alert to the possibility of its return. What makes it a clinical concern is when it becomes persistent, intrusive, and disproportionate to actual risk in ways that interfere with functioning, relationships, and quality of life.

The period before an imaging appointment or bloodwork result can be consumed by fear in ways that affect sleep, concentration, mood, and relationships. This does not have to be simply endured. Evidence-based approaches to managing fear of recurrence exist and are effective, including interventions that target intolerance of uncertainty and help survivors develop a more flexible relationship with not knowing.

What therapy support can look like

The emotional challenges of breast and gynecologic cancer are central parts of the experience of having cancer. Specialized psychological support can help in ways that matter for quality of life, treatment adherence, and long-term wellbeing.

As a psychologist who has both researched and provided clinical care in this area, I work with people navigating the full spectrum of the breast and gynecologic cancer journey, from the acute period following diagnosis through active treatment and into survivorship.

In my work with clients navigating breast and gynecologic cancer, we often focus on:

  • Processing the shock and grief of diagnosis; creating space for the full emotional weight of what has happened
  • Managing decision fatigue and scanxiety during treatment and surveillance
  • Building evidence-based coping skills for anxiety related to invasive procedures, including pelvic exams, biopsies, and brachytherapy
  • Naming the intersection of sexual violence history with gynecologic care and developing strategies for navigating procedures in ways that preserve a sense of safety and agency
  • Processing sexual health concerns and the grief, shame, or confusion that often accompany them, and working to address them using multidisciplinary approaches
  • Grieving fertility losses, bodily changes, and the pre-cancer self
  • Navigating the transition into survivorship including the fear, disorientation, and identity work that this transition often involves
  • Addressing fear of cancer recurrence and the anxiety that surrounds surveillance appointments
  • Reconnecting with values and meaning in life after cancer

I use Acceptance and Commitment Therapy for this work because it does not require the difficult feelings to be eliminated before a full life can be lived. It supports the development of psychological flexibility — the capacity to hold fear, grief, and uncertainty without those experiences dictating every decision or consuming every present moment.

When to seek support

Mental health support may be helpful when anxiety, grief, fear of recurrence, or other emotional challenges are significantly affecting daily functioning, relationships, sleep, or engagement with medical care. Therapy is also valuable when medical procedures and medical decision-making are significant sources of distress, when sexual health concerns are affecting quality of life, or when the transition into survivorship has brought unexpected difficulty.

You do not need to be in crisis to seek support. You do not need to wait until the emotional weight becomes unbearable. Many people find that beginning therapy during active treatment, rather than waiting until it is complete, provides meaningful support during one of the most demanding periods of their lives.

If someone is experiencing thoughts of self-harm or suicide, immediate support is needed. In the U.S., calling or texting 988 connects to the Suicide and Crisis Lifeline. If there is imminent danger, call 911 or go to the nearest emergency room.

If any of this resonates, and you're wondering if working with a specialist might help, I'd be glad to connect. You can reach me through my contact form or at contact@drjesscoleman.com.

Telehealth therapy for breast and gynecologic cancer

I provide telehealth therapy to adults in North Carolina, California, and 40+ PSYPACT states. I specialize in the psychological impact of breast and gynecologic cancer, including medical anxiety and procedural distress, fear of recurrence, grief related to fertility and bodily changes, sexual health concerns, and the emotional demands of survivorship. My work in this area is grounded in my research at Duke University, where I studied gynecologic cancer survivorship and developed evidence-based, trauma-informed approaches to coping with invasive medical procedures. Telehealth allows access to specialized support from wherever you are — including during active treatment when travel to in-person appointments may be difficult. You can reach me through the contact form on this site or by emailing contact@drjesscoleman.com.

Frequently Asked Questions

Is it normal to feel anxious or depressed after a breast or gynecologic cancer diagnosis?

Yes. Psychological distress, including anxiety and depression, is significantly more prevalent among people diagnosed with breast and gynecologic cancer than in the general population. The emotional impact of a cancer diagnosis is real, significant, and does not reflect inadequate coping or personal weakness. It reflects the genuine weight of what a cancer diagnosis involves for the body, identity, relationships, and the future. Professional support can make a meaningful difference in how people move through and beyond this experience.

What is scanxiety and how do I manage it?

Scanxiety refers to the anxiety that builds before and during cancer surveillance appointments: imaging, bloodwork, and follow-up exams that are necessary for monitoring but that can be accompanied by significant anticipatory fear. It is extremely common among cancer survivors and reflects the nervous system's response to having had a serious illness and remaining in a state of watchful waiting. Evidence-based approaches to managing scanxiety include building tolerance for uncertainty, developing practical coping skills for the pre-appointment period, and using mindfulness and relaxation strategies during procedures. Therapy can provide meaningful support for this specific challenge.

How does gynecologic cancer treatment affect sexual health?

Gynecologic cancer treatment affects sexual health through multiple pathways including direct changes to vaginal tissue from radiation and surgery, hormonal changes from treatment-induced menopause, and the psychological impact of changes in body image, identity, and intimacy. Sexual dysfunction affects many gynecologic cancer survivors, making it one of the most prevalent and least addressed aspects of survivorship. Sexual health concerns are legitimate medical and psychological concerns that deserve to be raised with your care team and addressed with appropriate multidisciplinary support.

Can I get help for anxiety about pelvic exams after cancer treatment?

Yes. Anxiety and distress during surveillance pelvic exams are common among gynecologic cancer survivors, and evidence-based interventions exist to address them. My research at Duke focused specifically on developing a cognitive behavioral coping skills program for gynecologic cancer survivors experiencing anxiety and distress during these procedures. The skills involved — including muscle tension release, mindfulness, and assertive communication with providers — are teachable and effective, and can meaningfully reduce the distress associated with these procedures. Therapy can help you develop and practice these skills in a supported context before applying them during appointments.

How does a history of sexual violence affect gynecologic cancer care?

A history of sexual violence can significantly affect a person's experience of gynecologic procedures, including the pelvic exams, biopsies, and other invasive procedures that are central to gynecologic cancer care. Research, including my own published systematic review from Duke, documents that survivors of sexual and physical violence often experience distress and pain during gynecologic exams. This intersection is both common and consistently underaddressed. Trauma-informed care from providers, combined with psychological support, can make a significant difference in helping people navigate their cancer care without being retraumatized in the process.

What is fear of cancer recurrence and when should I seek help for it?

Fear of cancer recurrence is the persistent concern that cancer will return — a feature of survivorship for a large proportion of people who have been treated for cancer. It may not simply resolve with time. It becomes a clinical concern when it is persistent, intrusive, and disproportionate to actual risk in ways that interfere with daily functioning, relationships, or engagement with follow-up care. Evidence-based therapeutic approaches for fear of recurrence exist and are effective. Therapy can help you develop a more flexible and sustainable relationship with uncertainty, including the uncertainty that is an inherent feature of survivorship after going through cancer.

Further Reading

Jess Coleman, Ph.D.
Previous

Coping During and After a NICU or PICU Stay
Next

Perfectionism, Guilt, and Shame in Parenthood